| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 43, 226-231, Copyright © 1996 by Canadian Anesthesiologists' Society
ARTICLES |
M Naguib, AK el Bakry, MH Khoshim, AB Channa, M el Gammal, K el Gammal, YS Elhattab, M Attia, R Jaroudi and A Saddique
Department of Anaesthesia, Surgery, Faculty of Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia. F35A002@SAKU00.
PURPOSE: Postoperative nausea and vomiting (PONV) is a distressing adverse effect of general anaesthesia. The aim of the current study was to compare the antiemetic activity of different 5-hydroxytryptamine3 receptor antagonists with that of metoclopramide and placebo. METHODS: In a prospective, randomized, double-blind study we have compared the antiemetic activity of the prophylactic administration of ondansetron 4 mg, tropisetron 5 mg and granisetron 3 mg with that of metoclopramide 10 mg and placebo in 132 patients undergoing laparoscopic cholecystectomy. All study drugs and placebo were given as a short iv infusion ten minutes before the induction of anaesthesia. Perioperative anaesthetic care was standardized in all patients. Nausea and vomiting were assessed by direct questioning of the patient at 1, 4, 9, 12, 18 and 24 hr after recovery from anaesthesia. If patients experienced nausea and/or vomiting, rescue antiemetic treatment (metoclopramide 10 mg iv) was administered. RESULTS: For the 24-hr recovery period after surgery, the percentages of emesis-free patients were 65.5%, 52%, 48%, 29.2% and 27.6% in the ondansetron, granisetron, tropisetron, metoclopramide and placebo groups, respectively. Prophylactic antiemetic treatment with ondansetron resulted in a lower incidence (P = 0.02) of PONV than with metoclopramide or placebo. The times at which rescue antiemetic was first received were longer (P < 0.01) in ondansetron group than in the placebo and metoclopramide groups. There were no statistical differences between ondansetron, tropisetron and granisetron groups. CONCLUSIONS: Ondansetron, when given prophylactically resulted in a significantly lower incidence of PONV than metoclopramide and placebo. Metoclopramide was ineffective.
This article has been cited by other articles:
![]() |
V. K. F. Kong and M. G. Irwin Gabapentin: a multimodal perioperative drug? Br. J. Anaesth., December 1, 2007; 99(6): 775 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White, J. Tang, M. A. Hamza, B. Ogunnaike, M. Lo, R. H. Wender, R. Naruse, A. Sloninsky, R. Kariger, S. Cunneen, et al. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. Anesth. Analg., May 1, 2006; 102(5): 1387 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goldfaden and J. D. Birkmeyer Evidence-Based Practice in Laparoscopic Surgery: Perioperative Care Surgical Innovation, March 1, 2005; 12(1): 51 - 61. [Abstract] [PDF] |
||||
![]() |
H. Yang, P. T.-L. Choi, J. McChesney, and N. Buckley Induction with sevoflurane-remifentanil is comparable to propofol-fentanyl-rocuronium in PONV after laparoscopic surgery: [L'induction avec sevoflurane-remifentanil ou propofol-fentanyl rocuronium est similaire quant aux NVPO en chirurgie laparoscopique] Can J Anesth, August 1, 2004; 51(7): 660 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Habib, W. D. White, S. Eubanks, T. N. Pappas, and T. J. Gan A Randomized Comparison of a Multimodal Management Strategy Versus Combination Antiemetics for the Prevention of Postoperative Nausea and Vomiting Anesth. Analg., July 1, 2004; 99(1): 77 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Habib, H. E. El-Moalem, and T. J. Gan The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials: [L'efficacite de la combinaison des antagonistes des recepteurs 5-HT3 et du droperidol ou de la dexame- thasone est similaire pour prevenir les NVPO. Une meta-analyse d'essais randomises et controles] Can J Anesth, April 1, 2004; 51(4): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Habib and T. J. Gan Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue] Can J Anesth, April 1, 2004; 51(4): 326 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Piper, S. W. Suttner, K. D. Rohm, W. H. Maleck, E. Larbig, and J. Boldt Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy: [Le dolasetron, non le metoclopramide, previent les nausees et les vomissements chez des patients qui subissent une cholecystectomie laparoscopique] Can J Anesth, December 1, 2002; 49(10): 1021 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Wang, S.-T. Ho, Y.-H. Uen, M.-T. Lin, K.-T. Chen, J.-C. Huang, and J.-I. Tzeng Small-Dose Dexamethasone Reduces Nausea and Vomiting After Laparoscopic Cholecystectomy: A Comparison of Tropisetron with Saline Anesth. Analg., July 1, 2002; 95(1): 229 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agarwal, N. Bose, A. Gaur, U. Singh, M. K. Gupta, and D. Singh Acupressure and ondansetron for postoperative nausea and vomiting after laparoscopic cholecystectomy: [L'acupression et l'ondansetron contre les nausees et les vomissements suivant la cholecystectomie laparoscopique] Can J Anesth, June 1, 2002; 49(6): 554 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Loewen, C. Marra, and P. Zed 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting Can J Anesth, October 1, 2000; 47(10): 1008 - 1018. [Abstract] |
||||
![]() |
L.H.J. Eberhart, W. Seeling, B. Ulrich, A.M. Morin, and M. Georgieff Dimenhydrinate and metoclopramide alone or in combination for prophylaxis of PONV Can J Anesth, August 1, 2000; 47(8): 780 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, A. Laupacis, G. A. Wells, D. L. Sackett, and for the Evidence-Based Medicine Working Group Users' Guides to the Medical Literature: XIX. Applying Clinical Trial Results; B. Guidelines for Determining Whether a Drug Is Exerting (More Than) a Class Effect JAMA, October 13, 1999; 282(14): 1371 - 1377. [Full Text] [PDF] |
||||
![]() |
K. B. Domino, E. A. Anderson, N. L. Polissar, and K. L. Posner Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting: A Meta-Analysis Anesth. Analg., June 1, 1999; 88(6): 1370 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R Tramèr, D J. M Reynolds, R A. Moore, and H. J McQuay When placebo controlled trials are essential and equivalence trials are inadequate BMJ, September 26, 1998; 317(7162): 875 - 880. [Full Text] |
||||
![]() |
R. A. Wiklund and S. H. Rosenbaum Anesthesiology- Second of Two Parts N. Engl. J. Med., October 23, 1997; 337(17): 1215 - 1219. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |